Laboratories are no longer peripheral. They are central to modern clinical development - enabling earlier decision-making, ...

Traditional trial start-up workflows often follow a sequential path, from feasibility to contracting, then regulatory submissions and, eventually, site staff training. This often creates bottlenecks ...

Alumis Inc. has announced the successful completion of patient enrollment in its pivotal Phase 3 ONWARD clinical program for ESK-001, a treatment for moderate-to-severe plaque psoriasis, involving ...